UBS Group’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,301,849
| Closed | -$60.3M | – | 7420 |
|
|
2019
Q2 | $60.3M | Buy |
1,301,849
+1,159,448
| +814% | +$53.7M | 0.02% | 482 |
|
|
2019
Q1 | $3.47M | Sell |
142,401
-34,909
| -20% | -$851K | ﹤0.01% | 2021 |
|
|
2018
Q4 | $2.53M | Buy |
177,310
+30,064
| +20% | +$428K | ﹤0.01% | 2251 |
|
|
2018
Q3 | $2.24M | Buy |
147,246
+45,388
| +45% | +$690K | ﹤0.01% | 2532 |
|
|
2018
Q2 | $1.71M | Sell |
101,858
-211,687
| -68% | -$3.55M | ﹤0.01% | 2660 |
|
|
2018
Q1 | $5.12M | Buy |
313,545
+217,672
| +227% | +$3.55M | ﹤0.01% | 1837 |
|
|
2017
Q4 | $1.23M | Buy |
95,873
+2,312
| +2% | +$29.6K | ﹤0.01% | 2869 |
|
|
2017
Q3 | $1.15M | Sell |
93,561
-21,844
| -19% | -$269K | ﹤0.01% | 2909 |
|
|
2017
Q2 | $966K | Buy |
115,405
+78,090
| +209% | +$654K | ﹤0.01% | 2939 |
|
|
2017
Q1 | $334K | Sell |
37,315
-130,204
| -78% | -$1.17M | ﹤0.01% | 3526 |
|
|
2016
Q4 | $1.47M | Buy |
167,519
+138,635
| +480% | +$1.22M | ﹤0.01% | 2517 |
|
|
2016
Q3 | $195K | Sell |
28,884
-52,191
| -64% | -$352K | ﹤0.01% | 3749 |
|
|
2016
Q2 | $289K | Buy |
81,075
+20,029
| +33% | +$71.4K | ﹤0.01% | 3517 |
|
|
2016
Q1 | $180K | Sell |
61,046
-241,469
| -80% | -$712K | ﹤0.01% | 3846 |
|
|
2015
Q4 | $1.28M | Buy |
302,515
+230,588
| +321% | +$973K | ﹤0.01% | 2523 |
|
|
2015
Q3 | $328K | Buy |
71,927
+10,556
| +17% | +$48.1K | ﹤0.01% | 3380 |
|
|
2015
Q2 | $443K | Buy |
61,371
+1,747
| +3% | +$12.6K | ﹤0.01% | 3353 |
|
|
2015
Q1 | $439K | Buy |
59,624
+629
| +1% | +$4.63K | ﹤0.01% | 3305 |
|
|
2014
Q4 | $279K | Buy |
+58,995
| New | +$279K | ﹤0.01% | 3546 |
|